🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CONGRESS|#ASCO23|Poster Haris Ali Haris Ali, MD, FACP, City of Hope presents the updated XPORT-MF-034 trial results showing that 60mg selinexor plus ruxolitinib demonstrated rapid and deep spleen responses across all subgroups, and was well tolerated in treatment-naïve pts with MF #MPNsm

Very important data from ASCO demonstrating an association between Agent Orange exposure and risk of MPN. To date MPN has not been considered a presumptive condition associated with AO and thus not compensated. Hopefully this will change. MPN Ad&Ed Int'l MPN Research Foundation #mpnsm Naveen Pemmaraju, MD

Eid Mubarak to all my friends celebrating today.

FDA Approves Momelotinib for Myelofibrosis With Anemia onclive.com/view/fda-appro…

Embrace the spirit of giving this Ramadan. Your small act of kindness can make a big difference. Join us in filling hearts and plates, one donation at a time through our Ramadan Food Drive Donate: mikaelrayaanfoundation.org/donate-now Zelle: 347 593 1080 Venmo: @mikaelrayaanfoundation

onlinelibrary.wiley.com/doi/10.1002/aj…

Dates are associated with fasting & the month of Ramadan. The nutritious fruits are not only the start of iftar meals but also a part of many desserts prepared during the holy month. But why are dates such an indispensable part of Ramadan food? A thread…

Today, at City of Hope, we celebrate the 48th BMT reunion. Dr. Forman, a pioneer in BMT, introducing donor to his patient. A truly magical moment.

How does #racial and #social #disparities in #CArT access affect outcomes? See below for our editorial on factors behind “race” as a barrier. 👇Race symbolizes structural barriers to timely access .. which can impact outcomes. Natalie Grover, MD . sciencedirect.com/science/articl….

🏥 New approaches make allogeneic #HSCT a safer therapeutic option for #myelofibrosis, improving outcomes for older patients. Haris Ali, MD, FACP City of Hope and Andrea Bacigalupo, MD emphasize early HSCT in their AmericanJournalofHematology review. Learn more: buff.ly/3xz31Bg #MedTwitter

Nico Gagelmann MPN_Hub Haris Ali, MD, FACP Prithviraj Bose MPN Ad&Ed Int'l @CanadianMpn Congrats!!!

FDA Approves Axatilimab for Patients With Chronic GVHD targetedonc.com/view/fda-appro…

Alex F. Herrera, MD, discusses long-term data from nivolumab plus AVD in advanced-stage Hodgkin lymphoma. City of Hope #OncClub #lymsm #oncology onclive.com/view/data-for-…

Splenectomy remains a viable option for JAKi resistant splenomegaly in MF #mpnsm Patricia Carey American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/aj…

Congratulations to Nico Gagelmann and colleagues on their NEJM publication and the critical discovery highlighting the significance of driver mutation clearance in transplant outcomes. The next step is to develop improved transplant strategies to build on this progress!

We mourn the loss of John A. Zaia, M.D., director of the Center for Gene Therapy at City of Hope. A beloved colleague for more than 40 years, Dr. Zaia was world renowned for his efforts to eradicate HIV and pediatric diseases. Read about his legacy: bit.ly/40WDsEQ

Savoring a berry parfait with a stunning view at the new City of Hope outpatient Hope Plaza— a perfect way to unwind after a long day of rounding and clinic.